|
|
Volumn 110, Issue 1, 2010, Pages 59-60
|
|
FDA raises safety issues concerning propoxyphene
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYP3A4 PROTEIN, HUMAN;
CYTOCHROME P450 3A;
DEXTROPROPOXYPHENE;
ENZYME INHIBITOR;
NARCOTIC ANALGESIC AGENT;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG POTENTIATION;
DRUG TOXICITY;
HUMAN;
INTOXICATION;
SHORT SURVEY;
ANALGESICS, OPIOID;
CYTOCHROME P-450 CYP3A;
DEXTROPROPOXYPHENE;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
DRUG TOXICITY;
ENZYME INHIBITORS;
HUMANS;
OVERDOSE;
|
|
EID: 74549165691
PISSN: 0002936X
EISSN: None
Source Type: Journal
DOI: 10.1097/01.NAJ.0000366058.52347.3f Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
